<DOC>
	<DOCNO>NCT02407457</DOCNO>
	<brief_summary>The objective post-market study evaluate Endologix AFX endovascular AAA system anatomical fixation approve Endovascular system proximal fixation . Multiple U.S clinical center involve study include broad range experience . Imaging data evaluate independent core lab .</brief_summary>
	<brief_title>Post-Market Study Assess Outcomes Patients Treated With AFX System Compared Other EVAR Devices</brief_title>
	<detailed_description>This study prospective , randomize , multi-center study , intend evaluate outcome contemporary EVAR ( Endovascular Aneurysm Repair ) real world population . The study design compare anatomically stabilize AFX Endograft System reference group proximally fixate EVAR device . Patients randomize two group . Randomization 1:1 . Each investigator select one comparator device choice enrol first patient . The study sequentially evaluate non-inferiority superiority hypothesis . Up 80 site experience EVAR 800 subject participate study .</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm , Abdominal</mesh_term>
	<criteria>1 . Male female least 18 year old 2 . Subjects minimum 2 year life expectancy 3 . Subjects sign informed consent document data release 4 . Subjects AAA eligible endovascular Abdominal Aortic Aneurysm Repair 1 . Currently participate another study primary endpoint reach yet 2 . Known allergy device component 3 . Pregnant ( female childbearing potential )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>